Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma

Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma

Glioblastoma is associated with poor prognosis with a mean survival of 15 months after diagnosis. The current standard of care includes surgery, radiation, and temozolomide with the use of tumor-treating fields in select patient population. The past decade has witnessed a convergence in our understa...

Full description

Bibliographic Details
Main Authors: Kunal Desai, Anne Hubben, Manmeet Ahluwalia
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Glioma
Subjects:
Checkpoint inhibition
checkpoint inhibitors
glioblastoma
glioma
oncolytic viruses
programmed cell death protein 1
programmed death-ligand 1
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=1;spage=7;epage=19;aulast=Desai

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=1;spage=7;epage=19;aulast=Desai

Similar Items